1.
Trevisan G, Germi L, Naldi L. Erythrodermic psoriasis improved by tildrakizumab. Dermatol Reports [Internet]. 2022 Nov. 23 [cited 2026 May 24];14(4). Available from: https://journals.pagepress.net/dr/article/view/9448